We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
MM
1126
MQS Management
New York
$523K +$79.8K +771 +17%
MWM
1127
MinichMacGregor Wealth Management
New York
$521K -$36.4K -351 -6%
Fayez Sarofim & Co
1128
Fayez Sarofim & Co
Texas
$520K +$11.5K +111 +2%
SWM
1129
Silverlake Wealth Management
Vermont
$520K -$9.11K -88 -2%
AF
1130
Advisornet Financial
Minnesota
$519K +$21K +203 +4%
BIAS
1131
Beacon Investment Advisory Services
New Jersey
$517K -$214K -2,062 -28%
RCA
1132
Resonant Capital Advisors
Wisconsin
$515K -$111K -1,069 -17%
WSCM
1133
Wellington Shields Capital Management
New York
$513K -$155K -1,500 -22%
EP
1134
Essential Partners
California
$512K -$3.73K -36 -0.7%
SG
1135
StoneX Group
New York
$511K -$70.4K -680 -12%
FFA
1136
Fairfield Financial Advisors
Massachusetts
$509K +$267K +2,575 +98%
CLOS
1137
Compagnie Lombard Odier SCmA
Switzerland
$509K -$19.4K -187 -3%
PGFC
1138
Peapack-Gladstone Financial Corp
New Jersey
$507K +$236K +2,277 +78%
PWMAG
1139
Pinnacle Wealth Management Advisory Group
New Jersey
$507K +$3.63K +35 +0.7%
ST
1140
Smithfield Trust
Pennsylvania
$501K -$145K -1,404 -22%
KCM
1141
Kathmere Capital Management
Pennsylvania
$499K +$17K +164 +3%
MIM
1142
MTM Investment Management
South Carolina
$498K -$69.9K -675 -12%
APP
1143
Avantax Planning Partners
Iowa
$496K +$30K +290 +6%
CT
1144
Caldwell Trust
Florida
$496K +$16.6K +160 +3%
IFG
1145
Independent Financial Group
California
$496K +$526K +5,077 New
RCP
1146
Rothschild Capital Partners
New York
$495K
EW
1147
Elyxium Wealth
California
$494K -$1.14K -11 -0.2%
ANBT
1148
American National Bank & Trust
Texas
$492K -$656K -6,330 -56%
IP
1149
Intellectus Partners
California
$490K +$520K +5,020 New
USCWA
1150
U.S. Capital Wealth Advisors
Texas
$489K +$49.4K +477 +11%

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.